Latham & Watkins Advises RIS Rx in Growth Investment by Summit Partners

RIS Rx, a healthcare technology company pioneering solutions to reduce revenue leakage in pharmaceutical gross-to-net spread, announced a significant growth investment from Summit Partners. This partnership will support RIS Rx’s continued innovation and growth in service of the company’s commitment to improving patient access to treatment, one prescription at a time.

Latham & Watkins LLP represents RIS Rx in the transaction with a corporate deal team led by Orange County/New York partner Charles Ruck and Century City partner Andrew Clark, with associates Shannon Cheng, Tyler Miller, Amy Lutfi, Ashley Campfield, and Joanna Yam. Advice was also provided on benefits matters by Los Angeles/Orange County partner Michelle Carpenter, with assistance from Kayla Snyder; on tax matters by Century City/Los Angeles partner Pardis Zomorodi and Houston partner Christine Mainguy, with associate Lucas Migliano; on healthcare regulatory matters by Washington, D.C. partners Jason Caron and Chris Schott, with associates Daniel Machado and Margaret Rote; on fintech regulatory matters by Washington, D.C. partner Barrie VanBrackle; on finance matters by Los Angeles partner Jason Bosworth; and on antitrust matters by Washington, D.C. partners Mandy Reeves and Patrick English and Bay Area counsel Jason Daniels, with associates Evan Omi and Hanna Nunez Tse.